Patents by Inventor Robert Jennings

Robert Jennings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190256399
    Abstract: A process for manufacturing glass articles from powder at low temperatures includes the steps of preparing a slurry of powder suspended in a liquid; depositing the slurry on a substrate; drying the slurry to form a layer on the substrate; depositing slurry on the layer; drying the slurry deposited on the layer on the substrate to form another layer; repeating the steps of depositing a slurry and drying the to form a plurality of sequential layers on the substrate; and consolidating the plurality of sequential layers to form a glass article. The process requires a small manufacturing footprint, and facilitates the manufacture of very large near-net shape glass articles.
    Type: Application
    Filed: February 18, 2019
    Publication date: August 22, 2019
    Inventors: Sezhian Annamalai, Thomas Richard Chapman, Kenneth Edward Hrdina, Douglas Hull Jennings, Nicolas LeBlond, Dale Robert Powers
  • Patent number: 10384499
    Abstract: A hitch mounted carrying assembly for transporting a door of a vehicle is presented. The assembly includes an adjustable mount configured to releasably communicate with a hitch of the vehicle. The mount is adjustable between an extended position and a retracted position. The assembly includes a modular frame assembly configured to translate along the adjustable mount and to selectively couple to a first location along the mount. The frame is configured to hold a door of the vehicle on a set of hinges and secured about a latch bar. The distance between the frame assembly and the vehicle is configured to change when the mount is adjusted between the extended position and the retracted position.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: August 20, 2019
    Assignee: MODIT, LLC
    Inventors: Robert Schocke, Dwayne Gates, Ron Segelquist, Corbett Jennings
  • Patent number: 10343634
    Abstract: An apparatus includes a vehicle structure, a bumper, an elongate structural member, and an extension portion. The elongate structural member is able to crush longitudinally in response to application of force in a longitudinal direction. The extension portion is able to crush longitudinally in response to application of force in the longitudinal direction, is connected to the elongate structural member such that the elongate structural member and the extension portion support the bumper with respect to the vehicle structure, and is operable to move the bumper between an extended position and a retracted position with respect to the vehicle structure to change a distance between the bumper and the vehicle structure.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: July 9, 2019
    Assignee: Apple Inc.
    Inventors: Erik Mikael Fermer, Alice C. Watts, Joel Frederic Jensen, Ronald Jack Smith, Mark B. Rober, Sung Hoon Kim, David Jennings Dostal, Russell Cranstoun Mead, Jr., Todd Elliot Lewis, Jesse T. Buehler, Nathaniel J. Dennis, Tommaso P. Rivellini, Robert R. Mayer, Anthony S. Montevirgen, Donald J. Parr, Bryce A. Woollard, Adam J. Golman, Kevin P. Makowski, Daniel E. Rivera
  • Patent number: 10308836
    Abstract: Polymeric dispersants are disclosed that include a urethane backbone at least one pendantly attached imide group, wherein the carbonyl of the imide are chemically bonded to a single or fused aromatic ring. The aromatic ring can be substituted with various electron withdrawing or releasing groups. The dispersant also includes solvent-solubilizing chains of polyether, polyester, polyacrylate, and or polyolefin Desirably, the imide groups are derived from an imide that has two isocyanate reactive groups such that the imide is attached to the urethane backbone at two separate locations.
    Type: Grant
    Filed: October 24, 2014
    Date of Patent: June 4, 2019
    Inventors: Andrew J. Shooter, Dean Thetford, Robert A. Jennings, Stuart N. Richards
  • Publication number: 20190161431
    Abstract: A reaction apparatus for producing polyethylene glycol dinitrate (PEGDN) in a continuous manner includes a series of reaction cells spatially disposed in one or more planar structures and a separation arrangement for separating PEGDN and Ammonium Nitrate, in a continuous manner. The separation arrangement is a thin film evaporator and/or falling film evaporator. The plurality of reaction cells includes a feed preparation section having feedstreams for continuously providing an acid composition and a glycol composition to reaction cells. The plurality of reaction cells further includes a nitration section, where the acid composition and the glycol composition react to generate a reaction composition, and a quench and neutralization section, having feed for cooling arrangement and a plurality of feeds for providing an alkaline composition to at least partially neutralize reaction composition. The acid composition includes a mixture of dilute nitric acid and concentrated sulphuric acid.
    Type: Application
    Filed: February 1, 2019
    Publication date: May 30, 2019
    Inventors: James Robert JENNINGS, Glyn David SHORT
  • Patent number: 10232341
    Abstract: An apparatus for producing polyethylene glycol dinitrate. The apparatus includes providing continuously an acid composition and a glycol composition to a reaction apparatus; reacting the acid composition and the glycol composition in the reaction apparatus in a continuous manner to generate a reaction composition; using an alkaline composition to at least partially neutralize the reaction composition to cause at least a portion of the polyethylene glycol dinitrate to deposit from a solution of the reaction composition; and extracting the deposit of polyethylene glycol dinitrate.
    Type: Grant
    Filed: February 15, 2016
    Date of Patent: March 19, 2019
    Assignee: AVOCET IP LIMITED
    Inventors: James Robert Jennings, Glyn David Short
  • Patent number: 10172830
    Abstract: Pyrazolone derivatives of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the treatment of diseases or conditions in which HNE is implicated.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: January 8, 2019
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Jonathan Mark Sutton, Robert Andrew Heald, Andrew Stephen Robert Jennings, Carmelida Capaldi, Elisabetta Armani
  • Patent number: 10113031
    Abstract: The present invention relates to a composition containing a particulate solid, an organic or aqueous medium and a dispersant that may be a reaction product of an organic di or polyepoxide with a primary amine, aminoalcohol, amino acid, hydroxyacid or alcohol containing a fused or non-fused aromatic imide group. The invention further provides compositions for coatings, inks, toners, plastic materials (such as thermoplastics), plasticizers, plastisols, crude grinding and flush.
    Type: Grant
    Filed: October 21, 2014
    Date of Patent: October 30, 2018
    Inventors: Dean Thetford, Andrew J. Shooter, Robert A. Jennings
  • Patent number: 10100050
    Abstract: Compounds of formula (I) defined herein are p38 MAPK inhibitors and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: October 16, 2018
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Carmelida Capaldi, Elisabetta Armani, Andrew Steven Robert Jennings, Christopher Hurley
  • Patent number: 10023558
    Abstract: Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the treatment of disease or conditions in which HNE is implicated.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: July 17, 2018
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Jonathan Mark Sutton, Robert Andrew Heald, Andrew Stephen Robert Jennings, Carmelida Capaldi, Elisabetta Armani
  • Publication number: 20180179967
    Abstract: A method of increasing efficiency of a combustion system, which runs with alcohol fuels, by injecting a controlled quantity of a fuel additive. The method includes using one of a single injector tip for pre-mixed alcohol fuel and fuel additive or individual injector tips for the alcohol fuel and the fuel additive. The fuel additive includes a mixture of organic compounds of which at least one organic compound includes at least one nitrate molecular group. The method further includes injecting the pre-mixed alcohol fuel and fuel additive or the alcohol fuel and the fuel additive individually into one or more combustion chambers of the engine block. The method also includes controlling a quantity of the fuel additive by a control arrangement associated with a temperature sensor, and controlling a flow-rate of the alcohol fuel by a power control adapted to controller an output power from the engine block.
    Type: Application
    Filed: July 3, 2015
    Publication date: June 28, 2018
    Inventors: James Robert JENNINGS, Glyn David SHORT
  • Patent number: 9994565
    Abstract: Compounds of formula (I) defined herein are p38 MAPK inhibitors and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: June 12, 2018
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Carmelida Capaldi, Elisabetta Armani, Andrew Steven Robert Jennings, Christopher Hurley
  • Publication number: 20180127410
    Abstract: Compounds of formula (I) defined herein are p38 MAPK inhibitors and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.
    Type: Application
    Filed: December 22, 2016
    Publication date: May 10, 2018
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Carmelida CAPALDI, Elisabetta ARMANI, Andrew Steven Robert JENNINGS, Christopher HURLEY
  • Publication number: 20180030361
    Abstract: A fuel for use in internal combustion engines, wherein the fuel includes a mixture of at least one alcohol, water, urea and/or Ammonium Nitrate. The water is included in a quantity which renders the Ammonium Nitrate and/or urea dissolved in the at least one alcohol. The at least one alcohol is methanol included in a concentration having a range of 90-97 weight %. The Ammonium Nitrate is included in a concentration having a range of 0.5-10 weight %; more optionally, the Ammonium Nitrate is included in a concentration having a range of 1-5 weight %. Further, the urea is included in a concentration having a range of 1-10 weight %.
    Type: Application
    Filed: February 15, 2016
    Publication date: February 1, 2018
    Inventors: James Robert JENNINGS, Glyn David SHORT
  • Publication number: 20180029004
    Abstract: An apparatus for producing polyethylene glycol dinitrate. The apparatus includes providing continuously an acid composition and a glycol composition to a reaction apparatus; reacting the acid composition and the glycol composition in the reaction apparatus in a continuous manner to generate a reaction composition; using an alkaline composition to at least partially neutralize the reaction composition to cause at least a portion of the polyethylene glycol dinitrate to deposit from a solution of the reaction composition; and extracting the deposit of polyethylene glycol dinitrate.
    Type: Application
    Filed: February 15, 2016
    Publication date: February 1, 2018
    Inventors: James Robert JENNINGS, Glyn David SHORT
  • Publication number: 20180009787
    Abstract: Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the treatment of disease or conditions in which HNE is implicated
    Type: Application
    Filed: September 22, 2017
    Publication date: January 11, 2018
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Jonathan Mark SUTTON, Robert Andrew Heald, Andrew Stephen Robert Jennings, Carmelida Capaldi, Elisabetta Armani
  • Patent number: 9862706
    Abstract: Imidazolone and pyrazolone derivatives of formula (I) described herein exhibit human neutrophil elastase inhibitory properties and are useful for the therapy of diseases and conditions in which HNE is implicated.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: January 9, 2018
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Carmelida Capaldi, Elisabetta Armani, Andrew Stephen Robert Jennings
  • Publication number: 20170354611
    Abstract: Microparticles are prepared by a method that includes: (a) forming a layer comprising a first polymer on a solid surface by depositing a first composition one or more times on the solid surface, wherein the first composition comprises the first polymer and a first solvent, and evaporating the first solvent in the first composition; (b) forming one or more layers comprising a second polymer and a therapeutic agent by depositing a second composition on all or part of the layer formed in step (a), wherein the second composition comprises the second polymer, the therapeutic agent, and a second solvent; and evaporating the second solvent in the second composition; and (c) forming an additional layer comprising a third polymer by depositing a third composition one or more times on a previously formed layer, wherein the third composition comprises the third polymer and a third solvent; and evaporating the third solvent in the third composition.
    Type: Application
    Filed: August 25, 2017
    Publication date: December 14, 2017
    Inventors: Chris Rhodes, Robert Jennings, Nikita Malavia, Laxma Reddy, Norman Betty
  • Publication number: 20170340611
    Abstract: Pyrazolone derivatives of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the treatment of diseases or conditions in which HNE is implicated.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Jonathan Mark SUTTON, Robert Andrew HEALD, Andrew Stephen Robert JENNINGS, Carmelida CAPALDI, Elisabetta ARMANI
  • Publication number: 20170342056
    Abstract: Imidazolone and pyrazolone derivatives of formula (I) described herein exhibit human neutrophil elastase inhibitory properties and are useful for the therapy of diseases and conditions in which HNE is implicated.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Carmelida CAPALDI, Elisabetta ARMANI, Andrew Stephen Robert JENNINGS